DiogenX SA raises €27.5M in Series A financing for type 1 diabetes work

DiogenX SA raises €27.5M in Series A financing for type 1 diabetes work

Source: 
European Biotechnology
snippet: 

French pancreatic beta-cell modulator specialist DiogenX SA has raised €27.5m in a Series A financing led by Boehringer Ingelheim Venture Fund and Roche Venture Fund.